Sorrento Therapeutics

March 16th, 2016 | Posted in 2016, Sorrento Therapeutics by

San Diego’s Sorrento Therapeutics and South Korean pharmaceutical company Yuhan formed ImmuneOncia Therapeutics, a joint venture, to develop and commercialize potential anti-cancer treatments.

ImmuneOncia will focus on immune checkpoint inhibitors against undisclosed targets in certain blood cancers and solid tumors.